BRCA2 and BRCA1 germline mutations were identified in patients 4453 and 4485, respectively, as a consequence of genetic testing in hereditary cancer clinics due to their breast and ovarian cancer family history (see Figure supplemental S1 for pedigree). The gene discussed is BRCA2; the disease is ovarian cancer.